Short Decsription
Creative Biolabs offers CHO-K1-Tg(Human GPR109A Receptor) Division-Arrested Cell which GPR109A receptor stably expressed in CHO-K1 cells.
Description
CHO-K1-Tg(Human GPR109A Receptor) Division-Arrested Cell was engineered to express the receptor human GPR109A (NM_177551.3). This cell line can be used to study GPR109A receptor function, signaling pathways, and potential therapeutic interventions. Dividing-arrest cells are cells that are normally kept under specific culture conditions or treated with agents that prevent cell division from being held in a non-dividing state. This can be achieved through methods such as serum starvation, chemical inhibitors of cell cycle progression, or genetic modification.
Features
Well-characterized stable cell lines;
for cell-based high-throughput screening;
Low-cost evaluation of stable cell lines or limited quantities of compounds.
Applications
GPR109A receptor function, signaling pathways, and potential therapeutic interventions.
Protein Target
GPCR
Receptor Name
GPR109A
Receptor Family
Nicotinic Acid
Species
Human
Parental Cell Line
CHO-K1
Transfection
Expression vector containing full-length human GPR109A cDNA (GenBank accession number NM_177551.3) with FLAG tag sequence at N-terminus
Gene
NM_177551.3
Background
GPR109A (HM74A, PUMA-G or niacin receptor 1) is a high-affinity receptor for nicotinic acid (niacin), and is highly expressed in adipocytes, lung, macrophages, dendritic cells, microglia and neutrophils. GPR109A in adipocytes is likely to be involved in niacin-mediated inhibition of lipolysis, reduction of serum free fatty acids and triglycerides as well as elevation of high density lipoproteins. GPR109A also serves important functions in the immune system. GPR109A on Langerhans cells in the skin also mediates niacin- induced cutaneous flushing, one of the major side effects of niacin, via the massive production of prostaglandins PGD2 and PGE2 in a ligand-dependent fashion.

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2024 Creative Biolabs. All Rights Reserved.